Injection delivery system developer ApiJect announced that it promoted Molly Weaver to the position of chief operating ...

Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation ...

MannKind announced top-level 30-week results from its Phase 4 INHALE-3 study comparing inhaled insulin to traditional ...

Eyenovia (Nasdaq:EYEN) announced that it began manufacturing batches of its Mydcombi product for its next-generation delivery ...

Ascensia Diabetes Care announced today that it launched the Eversense 365 CGM system from Senseonics (NYSE:SENS) ...

Stevanato Group announced today that it expanded the capacity of its Vertiva on-body device for subcutaneous large-volume ...

CereVasc shared data from a study demonstrating that its eShunt system may help deliver gene therapies to the central nervous ...

Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...

PCI Pharma Services announced that it's investing more than $365 million in infrastructure to support assembly and packaging ...

The MiniMed 780G with the Guardian 4 sensor. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced a voluntary recall warning of battery issues with its MiniMed 600 and 700 series insulin ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...